Bio-Rad Laboratories, Inc.Class A

BIONYSE • USD
386.00 USD
↘ 0.48 (0.12%)AT CLOSE (03:59 PM EST)
386.52
↗ 0.52 (0.13%)
POST MARKET (AS OF 05:08 PM EST)
Post Market
AS OF 05:08 PM EST
386.52
↗ 0.52 (0.13%)
🟢Market: OPEN

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $386.52. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 11, 2026.

Open?$388.31
High?$389.99
Low?$382.76
Prev. Close?$386.48
Volume?212.2K
Avg. Volume?246.8K
VWAP?$387.43
Rel. Volume?0.86x
Bid / Ask
Bid?$379.51 × 40
Ask?$386.18 × 40
Spread?$6.67
Midpoint?$382.85
Valuation & Ratios
Market Cap?10.4B
Shares Out?21.8M
Float?18.5M
Float %?85.2%
P/E Ratio?10.16
P/B Ratio?1.37
EPS?$38.04
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
10.4B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
85
Momentum?
69
Short Sent.?
64
Piotroski F-Score?5/9Mixed
Altman Z-Score?3.57Safe
Confidence?79%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?6.26%Elevated
Short Interest?1.2M
Days to Cover?5.1
Free Float18.5M
Avg Daily Volume228.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.18Strong
Quick Ratio?2.37Strong
Cash Ratio?0.48Low
Debt/Equity?0.16Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
72/100
P/E?
Peers
100
S&P
97
10.2CHEAP▾
P/B?
Peers
100
S&P
90
1.37CHEAP▾
P/S?
Peers
91
S&P
38
4.01FAIR▾
P/FCF?
Peers
82
S&P
26
31.6FAIR▾
EV/EBITDA?
Peers
27
S&P
3
69.3HIGH▾
EV/Sales?
Peers
91
S&P
43
4.29FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
49
13.5%STRONG▾
ROA?
Peers
60
S&P
72
9.5%STRONG▾
Cash Flow & Enterprise
FCF?$329.1M
Enterprise Value?$11.1B
Fundamentals ratios updated end of day